Whole recombinant yeast-based immunotherapy induces potent T cell responses targeting HCV NS3 and Core proteins.
| Image |  |
|---|---|
| Description | scientific article published on 10 November 2006 |
| Author/s |
author: Georg M Lauer |
| Publication date | November 10, 2006 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |